Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Eastnine AB publishes Interim report for the third quarter 2018

Key events during January - September: · Rental income¹ increased by 62.5% to EUR 6,614k (9M 2017: 4,070k) primarily due to acquisitions. Comparable rental income¹ increased by 4.9% · Occupancy was 97.5% (98.1%) · Average rent increased 3.5% to EUR 14.30/sqm/month · Net operating income¹ increased by 77.0% to EUR 5,569k (3,147k) · Profit from property management¹ increased to EUR 2,095k (-936k) · Unrealised value changes in properties amounted to EUR 4,620k (0), of which EUR 3,675k in Q3 following a revaluation of the completed third tower of 3Burės · Other unrealized

Isofol Announces Initiation of a Pivotal Phase 3 Clinical Trial of arfolitixorin for the Treatment of Metastatic Colorectal Cancer

GOTHENBURG, Sweden, November 15, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL) today announced initiation of the pivotal Phase 3 clinical trial, the ISO-CC-007 study, for the treatment of first-line (initial) metastatic colorectal cancer (mCRC).Anders Rabbe, chief executive officer of Isofol, said, "We look forward to bringing arfolitixorin to all patients in need of an improved therapy for metastatic colorectal cancer, a devastating disease with minor therapeutic advancements in the first line treatment over the past 15 years." Following completion of the Special

Diamyd Medical updates on the Company and the diabetes vaccine Diamyd® ahead of the Annual General Meeting today

At today's Annual General Meeting, CEO Ulf Hannelius presents the latest developments with the diabetes vaccine Diamyd®. Presentations will be held by Professor Per-Ola Carlsson, Uppsala University Hospital and Uppsala University and Professor Johnny Ludvigsson, Linköping University. Professor Mark A. Atkinson, University of Florida, USA, who is joining the Company’s Board of Directors , will participate via video link. The meeting will be held at 5:00 pm CET in Stockholm.Diamyd Medical's main focus with regard to the diabetes vaccine Diamyd® is to increase the international awareness about

Successful Agar/Plantain Exploration Well (UK)

15 November 2018     Faroe Petroleum plc     ("Faroe", "Faroe Petroleum", the "Company")  Successful Agar/Plantain Exploration Well (UK)  Faroe Petroleum, the independent oil and gas company focusing principally on exploration, appraisal and production opportunities in Norway and the UK, is pleased to announce a successful result with the Agar/Plantain exploration and appraisal well in licence P1763 (Faroe 25% of Agar/Plantain, 12.5% of the wider licence), located in the UK Continental Shelf ("UKCS").  Highlights  ·  Recoverable resources in Agar estimated between

Interim Report January-September 2018

With the new financing in place for the next three years, Bong is now ready to continue the business development within both envelopes and light packaging. The positive sales trend continued for both segments in the third quarter. The profit margin increased slightly during the third quarter despite the continued price increases on raw material, says Bong’s CEO Kai Steigleder.July – September 2018 · Net sales increased to SEK 536 million (491) · Operating profit before depreciation increased to SEK 22 million (13) · Operating profit increased to SEK 12 million (2) · Earnings

Zinzino AB (PUBL): Interim Report for the third Quarter 2018

Strong growth in combination with a good profitability driven by positive development in Central Europe.Launch of a new digital tool during the third quarter, in combination with Zinzino’s effort of engaging distributors in different markets resulted in a 16% growth in sales compared to the same period last year. The Nordic countries accounted for 70% of the turnover but Germany, Switzerland, Austria, Spain, Rumania and Hungary continue to increase strongly during the third quarter. In addition to investing in the new digital sales tools Zinzino has expanded the activities in Hungary and

Heroes of Warland launched on iOS and Android

Nitro Games announced the launch of its new mobile game on the App Store and the Google Play store. Nitro Games’ new game Heroes of Warland is now available on Android on the Google Play store and iOS on the App Store. The game has previously been available on Huawei AppGallery, exclusively for a limited time. ”Heroes of Warland is a unique combination of accessibility and competitive skill-based gaming on your smartphone. We’re now looking forward to bringing this experience to wider audiences and serving our growing player base with regular updates and new content,“ says

OxThera AB is being granted US patent for Oxalobactersecretagogues

OxThera AB, a privately-held Stockholm-based biopharmaceutical company, today announced a granted US patent on Oxalobacter formigenes secretagogues. Oxabact® , a formulation of highly concentrated lyophilized Oxalobacter formigenes, is being developed by OxThera AB as a potential treatment for patients with primary hyperoxaluria (PH). Oxabact® is designed to increase the intestinal secretion of oxalate from  plasma and thereby decrease and prevent oxalate crystal accumulation and kidney deterioration. Oxalobacter formigenes produces specific secretagogues that enhance active

Viking Line: Business Review for the period January - September 2018

Viking Line Abp              BUSINESS REVIEW              15.11.2018, 9.00 AM BUSINESS REVIEW FOR THE PERIOD JANUARY–SEPTEMBER 2018 Consolidated sales of the Viking Line Group for the period January 1–September 30, 2018 were 378.1 million euros (EUR 392.1 M for the period January 1–September 30, 2017). Other operating revenue amounted to EUR 0.2 M (1.3). Operating income totalled EUR 7.7 M (6.3). Net financial items totalled EUR -2.1 M (-1.7). Consolidated income before taxes amounted to EUR 5.6 M (4.6). Income after taxes totalled EUR 4.8 M (3.8). Competition in Viking Line’s

Lars Thunell is nominated to Azelio’s Board of Directors

With solid and senior experience in both power and finance, Lars Thunell provides valuable knowledge to further strengthen Azelio's offering on the global energy market.Azelio goes from a phase of development to industrialization of its offer. At this stage, a strengthening is proposed to Azelio's Board of Directors through the nomination of Lars Thunell. A formal decision of the position, supported by the majority of the owners, is taken at a forthcoming extraordinary general meeting. Lars Thunell is today a private investor and Chairman of Flexenclosure AB and EcoDataCenter AB. He was

Interim report January 1 – September 30, 2018

RaySearch Laboratories AB (publ) “In the third quarter of 2018, order intake rose 31 percent to SEK 176 M (134), the highest-ever order intake for the third quarter. Net sales rose 35 percent to SEK 150 M (112) and the operating margin to 8 percent (1), despite changes in accounting policies that are deferring our revenue recognition. Without application of the new accounting policies, net sales would have risen 47 percent to SEK 164 M and the operating margin would have been 15 percent. We have confidence in our long-term strategy, and our expansion will continue,” says Johan Löf, CEO

Elekta’s Nomination Committee for the 2019 Annual General Meeting

STOCKHOLM, November 15, 2018 – In accordance with the resolution passed by Elekta’s (EKTA-B.ST) Annual General Meeting on August 30, 2018, the Chairman of the Board has summoned a Nomination Committee prior to the 2019 Annual General Meeting by contacting the company’s four largest shareholders in terms of votes, in addition to the shareholder or shareholders represented by the Chairman himself. The procedure is described in detail in the notice of the 2018 Annual General Meeting.The Nomination Committee consists of: · Laurent Leksell, in his capacity as Chairman of the Board of Elekta

Hunter Group ASA Third Quarter Results 2018

Financial highlights •Net Profit from continuing operations came in at NOK 5.2m in Q3 2018  •Total operating expenses from continuing operations was NOK 1.6m. •Adjusted Cash position as of 30.9.2018 was NOK 717,9m consisting of NOK 306m and USD 51,45m Key events in Q3 2018 •On 6 July the NOK 52m subsequent offering was successfully completed at a price of NOK 3.2/sh. •On 7 July USD 20m was purchased at a USDNOK rate of 8.0. •On 15 August the Company received an Extension on the declaration date for the Option Vessels until 17 September. Option price is still USD 92m/

Ambea repurchases own shares

The Board of Ambea AB (publ) has resolved to initiate a share buyback program for a total of 50,677 shares until May 16, 2019.Repurchased shares will be saved to be used under Ambea’s share savings plan. The buyback program will be managed by a securities company or credit institution that makes its trading decisions regarding Ambea’s shares independently of, and without influence by, Ambea with regard to the timing of the repurchases. The buyback program shall meet the following terms:  1. Repurchases of shares are to be made on Nasdaq Stockholm and in accordance with Nasdaq

Veidekke ASA: Increased revenues and order book

Veidekke boosted its revenues by 11% in the third quarter and delivered pre-tax profit of NOK 460 million. The company’s order book increased to NOK 33.8 billion.“Although Veidekke has delivered higher revenues, we are not satisfied with our recent profitability trend. Over the past months we have therefore implemented organisational changes and have introduced a stricter risk assessment regime. We have also introduced measures to cut costs and are being more selective with regards to which new projects we consider taking on,” says Arne Giske, Group CEO of Veidekke. Veidekke achieved

Clas Ohlson increase sales in October

Sales in October increased by 10 per cent compared with October last year, corresponding to an organic growth of 6 per cent. For this fiscal year’s first six months organic growth is in line with the growth target of 5 per cent. Clas Ohlson’s online sales growth in October amounted to 56 per cent.October sales increased by 10 per cent to 755 MSEK (688). Organic sales increased by 6 per cent compared with the preceding year. Sales in October in comparable units and local currency increased by 2 per cent. Sales in October were positively impacted by a calendar effect of approximately 2

Catella AB – Interim Report January-September 2018

Income increased by 3% to SEK 472 M, while operating profit decreased by 18% to SEK 90 M year-on-year in continuing operations. The decrease in operating profit was mainly due to lower variable earnings from managing the funds in the Equity, Hedge and Fixed Income Funds operating segment. The Catella Group’s assets under management continued to increase and were up by SEK 28.5 Bn year-on-year, with growth of SEK 3.3 Bn in the third quarter 2018.THIRD QUARTER 2018 · Total income SEK 472 M (457) · Net sales SEK 465 M (455) · Operating profit SEK 90 M (109) · Profit/loss before

New diabetes drug may increase the risk of serious adverse events

[PRESS RELEASE 2018-11-15] The use of a new class of drugs in the treatment of type 2 diabetes, so called SGLT2 inhibitors, are linked to a twofold increased risk for lower-limb amputation as well as diabetic ketoacidosis, a serious diabetes complication. This is according to a Nordic study headed by researchers at Karolinska Institutet and published in the journal BMJ.Nearly every tenth person over the age of 18 across the world has diabetes and the number of patients is expected to increase in the next few decades. Patients with diabetes can develop several complications, such as diseases

SDRL - Completion of mandatory offer to purchase up to US$56 million of its 12.0% Senior Secured Notes due 2025

Hamilton, Bermuda, November 14, 2018 - Seadrill Limited ("Seadrill" or the "Company") announces the completion of the mandatory offer to purchase approximately US$56 million (the "Asset Sale Offer") of its 12.0% Senior Secured Notes due 2025 (the "Notes") announced on October 10, 2018 related to the proceeds of a deferred consideration agreement with Sapura Energy. The Asset Sale Offer expired at 5:00 p.m., New York City time, on November 9, 2018 (the "Expiration Time"). As of the Expiration Time, $148,243 in aggregate principal amount of the Notes were validly tendered.  The Company

Ripasso Energy announces correction in the half-year report for 2018

Ripasso Energy AB (publ) announces that corrections have been made in the company’s half-year report for 2018 since an internal review revealed discrepancies.Ripasso Energy has corrected its half-year report for 2018 since the company, during an internal review, detected discrepancies. These led to that the company’s profit/loss for the period was reported to SEK -10,318,000. The correct figure for the period was SEK -7,389,000. The company has adjusted the half-year report, which is now available on the company’s website. The report for the third quarter of the year that the company

Hoist Finance updates on strategy and financial targets

Tomorrow Hoist Finance hosts its Capital Markets Day 2018 in Stockholm, Sweden.The management will present the Group’s new strategy. The strategy addresses opportunities present in the European non-performing loan market. Presentations will be given on Hoist Finance key value creation initiatives. These include actions to: · capture the strong growth in six priority markets (Italy, UK, Poland, France, Germany and Spain); · extend its product offering to meet more of the needs of European Financial institutions; · expand into other asset classes, including SME Unsecured, B2C

Revenio Group Corporation: SHARE REPURCHASE 14.11.2018

Revenio Group Plc                ANNOUNCEMENT           14.11.2018 SHARE REPURCHASE 14.11.2018 In the Helsinki Stock Exchange Trade date 14.11.2018Bourse trade BUYShare REG1VAmount 7 000 sharesTotal cost 98 867,30 EURAverage price/ share 14,1239 EUR Company now holds a total of 44.867 sharesincluding the shares repurchased on 14.11.2018. On behalf of Revenio Group Plc. Nordea Bank Oyj Janne Sarvikivi         Ilari IsomäkiFurther information: Timo Hildén, CEO,tel.  +358 40 580

Report from Extraordinary General Meeting - SaltX Technology Holding AB (publ) vote on rights issue

Stockholm November 14, 2018 At today's Extraordinary General Meeting (EGM) of SaltX Technology Holding AB (publ), it was decided, in accordance with the Board's proposal, to do a rights issue of shares of series B and warrants of series TO6 ("Units") and to authorize the Board to decide on issues of Units. Upon full subscription of the rights issue, the company will receive approximately SEK 80.6 million before issue costs.The EGM voted in favor of following decisions. All decisions were in accordance with the submitted proposals and are described in detail in the EGM documents available

Martin Luther

Learn about the man behind the name“How do we know what Martin Luther  looked like?” “Where did he go to school?” “What did he eat for dinner?” These are just some of the questions that tour guides in LutherCountry  have fielded in the past few months. The 2017 celebrations marking the 500th anniversary of the Reformation have renewed interest in Luther, the German monk, who changed world history. And the full story lies in the German federal states of Thuringia and Saxony-Anhalt, just south of

There are no items matching the current filter
There are no more items matching the current filter
Back to top